.FDA declines experimental MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Decreases to Permit MDMA Therapy, Looking For Even More Research Study The New York TimesFDA Declines Ecstasy-Based Medication The Exchange JournalFDA declines to approve unique MDMA therapy to manage post-traumatic stress disorder, with request for additional litigation data CNNFDA refuses initially psychedelic to manage PTSD, requiring more research The Washington Message.